Share
Brendan Strong
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company focused on developing innovative cancer therapies, announced the appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications.
Mr. Strong brings extensive experience in investor relations, corporate communications, and financial strategy. Most recently, he served as Managing Director at Argot Partners, advising biopharmaceutical companies on investor engagement and communications.
Prior to that, he led investor relations at Tenet Healthcare and also served as Chief Financial Officer for Tenet's Massachusetts Market. His career also includes roles in equity research at Lehman Brothers and Barclays, as well as participation in a financial leadership training program at AT&T.
Mr. Strong holds an MBA from Harvard Business School and a B.S. in Finance from Rutgers University.
